Legend Biotech (LEGN) Misses Q1 EPS by 6c

Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $195.05 million versus the consensus estimate of $192.54 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Citi positive on Deckers Outdoor ahead of earnings
• ASML Holding NV (ASML:NA) (ASML) PT Raised to EUR2,000 at Goldman Sachs
• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS